Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study. - Wikidata - awgldk - TriplyDB

Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study.

Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study.

http://www.wikidata.org/entity/Q37725603

about

Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma.Emerging role of precision medicine in biliary tract cancers Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma

P2860

Q47130749-5F872297-88E5-4376-ABFF-1915E8D1A929 Q57298169-70171BD4-ED6D-44A3-909C-4B6500EBFAD8 Q58450461-F9CB6B2C-FD55-4397-BB48-BF9CA9641DDB Q58761822-A6754ADB-6BF0-49EF-94BC-D61EC38C3C45

P2860

Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study.

http://www.wikidata.org/entity/Q37725603

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effectiveness and safety of so ...... angiocarcinoma: a pilot study.

@en

Effectiveness and safety of so ...... angiocarcinoma: a pilot study.

@nl

type

label

Effectiveness and safety of so ...... angiocarcinoma: a pilot study.

@en

Effectiveness and safety of so ...... angiocarcinoma: a pilot study.

@nl

prefLabel

Effectiveness and safety of so ...... angiocarcinoma: a pilot study.

@en

Effectiveness and safety of so ...... angiocarcinoma: a pilot study.

@nl

P1433

Q37725603-99E2995E-F7E3-4B20-A243-67B478497DB1

P1476

Q37725603-62CF294D-B840-4BBB-8A2B-E7B5CAA752BF

P2093

Q37725603-0219F1DA-909F-45C3-9553-3D5185ACCA77

Q37725603-0602BBA2-0524-46F0-B108-2E34FB725EC1

Q37725603-1B754895-3CCB-4B76-B1E0-F30900864F5C

Q37725603-1DF82723-D078-454C-BD7F-98C22707956A

Q37725603-27662E8F-B9B0-442A-B925-711F9CDA66C6

Q37725603-8C2277AE-BC50-4DFA-AA2D-9EB825E173B6

Q37725603-9759A781-2B4D-459D-9A1F-D8D227183F6B

Q37725603-A2A7BACF-DD4F-406E-9A1C-BA7BE4BFD5EE

Q37725603-AB8133AD-87F3-4222-B448-6A3877081CE1

Q37725603-ADDF9AE4-D4F7-4FEA-B346-3ED4A090A3FC

P2860

Q37725603-06CD4393-5DD7-490D-885D-054A854D5EF8

Q37725603-06CDC4EF-F726-4647-9EAB-1E83FF5B7D8C

Q37725603-1132F26E-1B6F-44A6-A39D-1D592DF88195

Q37725603-15B77EBC-E885-4795-95B2-C93995568C13

Q37725603-25408A13-6ABF-40DE-9BAF-8CF64E8DDED2

Q37725603-2A8E92AC-9861-497E-9DAE-EDA148BCC0AE

Q37725603-2DE6C480-AE88-4039-A113-7690D0836BD7

Q37725603-3331259F-28F4-41DF-853D-45A5FB8D1B06

Q37725603-37165DBC-8062-4D98-BFE9-7956DE2D248E

Q37725603-40F73679-C139-44A5-8CAC-E828FCD1ABC2

P304

Q37725603-0CB48994-5DC1-4B37-9A6E-35016BA86269

P31

Q37725603-01EFED80-2CAE-4E8F-87A6-116C1BB0C83C

P356

Q37725603-235351F0-49F7-4CE2-81F3-E344CBE8ABD3

P407

Q37725603-DFDDC6B1-BC28-4628-84FC-90FB30AF8830

P433

Q37725603-DE09BC25-5CCD-489A-BE58-717D4E0A6E79

P478

Q37725603-BF3A2105-1617-480E-A677-A2261142A020

P50

Q37725603-CD101FD4-B80A-41C8-AEA2-E571A2D46107

P577

Q37725603-BE4C5EFA-E6AD-42D8-8CCD-347C36D595AD

P698

Q37725603-9F2BC9DD-A1AF-4A88-AFD0-E7E760ED064D

P921

Q37725603-A3B54015-7E63-4690-AED6-2A145E99A1EB

P932

Q37725603-85A7DEC0-CB1E-4B32-BE25-3EDE072457F4

P356

ONCOTARGET.12825

P1433

P1476

Effectiveness and safety of so ...... angiocarcinoma: a pilot study.

@en

P2093

Anfeng Si

http://www.w3.org/2001/XMLSchema#string

Baocai Xing

http://www.w3.org/2001/XMLSchema#string

Chunfang Gao

http://www.w3.org/2001/XMLSchema#string

Feng Shen

http://www.w3.org/2001/XMLSchema#string

Jun Li

http://www.w3.org/2001/XMLSchema#string

Wan Yee Lau

http://www.w3.org/2001/XMLSchema#string

Weidong Jia

http://www.w3.org/2001/XMLSchema#string

Xiangcheng Li

http://www.w3.org/2001/XMLSchema#string

Xiangji Luo

http://www.w3.org/2001/XMLSchema#string

Xiaoqing Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer.

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study.

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

Systemic gemcitabine combined with hepatic arterial infusion chemotherapy with cisplatin, 5-fluorouracil, and isovorin for the treatment of advanced intrahepatic cholangiocarcinoma: a pilot study.

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial.

Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

P304

17246-17257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.12825

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27783997

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

5370037

http://www.w3.org/2001/XMLSchema#string